Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA , Oct. 13, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): Grabar Law Office is investigating whether certain officers and directors of DoubleVerify Holdings, Inc....
-
PHILADELPHIA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): Grabar Law Office is investigating whether certain officers and directors of DoubleVerify...
-
PHILADELPHIA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of...
-
PHILADELPHIA, June 25, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): If you have held DoubleVerify Holdings, Inc. (NYSE: DV) shares since prior to November 10, 2023, and would...
-
PHILADELPHIA, June 17, 2025 (GLOBE NEWSWIRE) -- Maison Solutions Inc. (NASDAQ: MSS) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of...
-
Robbins LLP is Investigating Allegations that Treace Medical Concepts, Inc. (TMCI) Misled Investors Regarding Demand for its Primary Product
-
PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- If you have held Treace Medical Concepts (NASDAQ: TMCI) shares continuously since prior to May 8, 2023, you can seek corporate reforms, the return of...
-
Robbins LLP is Investigating Allegations that Treace Medical Concepts, Inc. (TMCI) Misled Investors Regarding Demand for its Primary Product